Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Study Site Opens for Phone Screening in Tel Hashomer, Israel

On February 3, our Phase 3 study site for MDMA-assisted psychotherapy for PTSD in Tel Hashomer, Israel, officially opened for phone screenings and informed consent visits. Led by Principal Investigator Jana Yakirevitch, M.D., this is an FDA-regulated Phase 3 clinical trial of MDMA-assisted psychotherapy for PTSD. 

We conduct clinical trials in the U.S. under the guidance and regulations of the U.S. Food and Drug Administration (FDA) in collaboration with federal regulators, including the Drug Enforcement Administration (DEA) and appropriate regulatory bodies in other countries. To learn more about our clinical trials or apply to be a study participant, visit our website. Additional information can be found at